Breaking News
Get 55% Off 0
🔺 What to do when markets are at an all-time high? Find smart bargains, like these.
See Undervalued Stocks

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Top 7 Research Reports For July 8, 2016 By Zacks Investment Research - Jul 08, 2016

Friday, July 8, 2016This write-up features research reports issued by our team of analysts on 17 stocks, which we hand-picked from the roughly 80 research reports issued by the team today. We are...

Why Is Resolute Energy Stock (REN) Soaring 16.6% Today? By Zacks Investment Research - Jul 08, 2016

Resolute Energy (NYSE:REN) is up 16.6% on news that the company sold some of its midstream assets in the Permian Basin to an undisclosed buyer for $110M.The Denver, CO based company is an...

Why Is Juno Therapeutics (JUNO) Stock Plunging 31% Today? By Zacks Investment Research - Jul 08, 2016

On Friday, shares of biopharmaceutical company Juno Therapeutics Inc. (NASDAQ:JUNO) are plunging, down around 31% as of 10:36 AM EST after three patients died in a trial for its leading cancer...

Alnylam (ALNY) Begins Phase I/II Study On Chronic HBV Drug By Zacks Investment Research - Jul 07, 2016

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) announced that it has initiated a phase I/II study on one of its pipeline candidates, ALN-HBV, which is a subcutaneously administered experimental RNAi...

Aqua America (WTR) Continues To Expand Via Acquisitions By Zacks Investment Research - Jul 07, 2016

Water and wastewater service provider Aqua America Inc. (NYSE:WTR) announced that its subsidiaries completed three acquisitions in the second quarter of 2016. Like most of its peers in the water...

Puma (PBYI) Stock Up, Phase II Data On Neratinib Published By Zacks Investment Research - Jul 07, 2016

Puma Biotechnology, Inc. (NYSE:PBYI) announced that positive results from a randomized phase II study (I-SPY 2 – Investigation of Serial Studies to Predict Your Therapeutic Response with...

FirstEnergy's (FE) Units On Infrastructure Upgrade Drive By Zacks Investment Research - Jul 07, 2016

Diversified energy company FirstEnergy Corporation’s (NYSE:FE) units are making a slew of investments to upgrade infrastructure.The objective of these investments is to modernize the electric...

Boeing Reports Q2 Deliveries: Commercial Up, Defense Drags By Zacks Investment Research - Jul 07, 2016

The aerospace behemoth The Boeing Company (NYSE:BA) reported second-quarter 2016 deliveries wherein commercial deliveries were up 1% whereas defense shipments were down 19.6% year over year.BOEING...

Grupo Televisa (TV) Q2 Earnings Miss, Revenues Lag Y/Y By Zacks Investment Research - Jul 07, 2016

Mexican pay-TV and broadcasting behemoth Grupo Televisa S.A.B. (NYSE:TV) reported weak financial results in the second quarter of 2016. While the bottom line missed the Zacks Consensus Estimate, the...

Buy These 5 Stocks With Sturdy Earnings Growth Now By Zacks Investment Research - Jul 07, 2016

Even if it is a fledgling company or an established corporation, the highest priority will be to secure earnings growth on a year-over-year basis. But, what exactly do earnings represent and why do...

Q2 Earnings To Gather Steam: 4 Sector ETFs & Stocks To Play By Zacks Investment Research - Jul 07, 2016

The second-quarter earnings season has started hogging attention, sending Brexit to the backseat. This is especially true as U.S. corporate earnings have been in the grip of recession over the last...

SunPower (SPWR) Gets Lion's Share Of France's ZNI Tender By Zacks Investment Research - Jul 07, 2016

SunPower Corporation (NASDAQ:SPWR) announced that it has been successful in winning 76% of the French government's tender for supplying the country's ZNI (non-interconnected zones) with green energy...

Brexit Fuels A Global Rally In Bond ETFs By Zacks Investment Research - Jul 07, 2016

Brexit fears have begun to haunt the markets yet again. The British pound has sunk to a new 31-year low thanks to speculation regarding rate cuts by the Bank of England apart from concerns relating to...

Catabasis' DMD Drug In Phase II Open-Label Extension Study By Zacks Investment Research - Jul 07, 2016

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) announced that it has initiated an open-label extension (Part C) of the phase II portion of its MoveDMD study (phase I/II) on edasalonexent (CAT-1004)....

Illumina Stock Hit By Downbeat Guidance, Stiff Competition By Zacks Investment Research - Jul 07, 2016

On Jul 5, 2016, we issued an updated research report on San Diego, CA-based Illumina Inc. (NASDAQ:ILMN) , a company that provides tools and integrated systems for the analysis of genetic variation...

Continue with Apple
Continue with Google
or
Sign up with Email